Snakebite envenoming

  title={Snakebite envenoming},
  author={Jos{\'e} Mar{\'i}a Guti{\'e}rrez and Juan J. Calvete and Abdulrazaq Garba Habib and Robert A. Harrison and David J. Williams and David A. Warrell},
  journal={Nature Reviews Disease Primers},
Snakebite envenoming is a neglected tropical disease that kills >100,000 people and maims >400,000 people every year. Impoverished populations living in the rural tropics are particularly vulnerable; snakebite envenoming perpetuates the cycle of poverty. Snake venoms are complex mixtures of proteins that exert a wide range of toxic actions. The high variability in snake venom composition is responsible for the various clinical manifestations in envenomings, ranging from local tissue damage to… 

Snakebite Envenoming Diagnosis and Diagnostics

This review aims to highlight regional differences in epidemiology and clinical snakebite management on a global scale, including an overview of the past and ongoing research efforts within snakebite diagnostics.

PLOS Neglected Tropical Diseases broadens its coverage of envenomings caused by animal bites and stings

To broaden the coverage of a variety of conditions that share the features of currently recognized neglected tropical diseases, PLOS Neglected Tropical Diseases will accept manuscripts dealing with scorpions and spiders, insects, jellyfish, and other marine creatures, in addition to snakebite envenoming.

Perspective on the Therapeutics of Anti-Snake Venom

Specific therapeutic snakebite envenomation treatments are described and an increased number of literature reports on the ability of natural sources, particularly plants, to treat snakebites are covered, along with their mechanisms, drawbacks and future perspectives.

Cost of Manufacturing for Recombinant Snakebite Antivenoms

The development of recombinant antivenoms not only holds a promise for improving therapeutic parameters, such as safety and efficacy, but could possibly also lead to a more competetive cost of manufacture of antivenom products for patients worldwide.

Evolution Bites — Timeworn Inefficacious Snakebite Therapy in the Era of Recombinant Vaccines

The influence of ecology and evolution in driving inter- and intra-specific venom variations in snakes is highlighted, and the repercussions of this molecular variation on the effectiveness of the current generation Indian antivenoms in mitigating snakebite pathologies are described.

Plants and phytocompounds active against Bothrops venoms.

Natural compounds isolated from plants, mainly from those used in folk medicine to treat snakebite, are a good choice for finding new lead compounds to improve snakebite treatment and minimize its consequences for the victims.

Bothrops Snakebite Envenomings in the Amazon Region

In a context of global efforts to reduce the impact of snakebite envenomings, there is a need for international cooperative efforts by public health authorities and civil society in these countries.

Ketamine for pain control of snake envenomation in Guinea: A case series.

Review Article: Snake Envenomation in Africa

With the new designation of snakebite envenoming as a category A neglected tropical disease, an active WHO working group, and several independent groups focusing on a multidisciplinary approach to improve key gaps in knowledge and apply new treatment modalities, it can greatly decrease the morbidity and mortality associated with snakebite in Africa.

Antibodies as Snakebite Antivenoms: Past and Future

Monoclonal antibodies and their fragments are described as a possible alternative for the production of antivenoms, regardless of the venom, despite the fact that venoms are a complex mixture of components.



Snakebite envenoming from a global perspective: Towards an integrated approach.

From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy.

Current state of the-art in biopharmaceutical antitoxin development is presented together with an overview of available bioinformatics and structural data on snake venom toxins, which could define the basis for introducing a rational drug design approach into the field of snakebite envenoming therapy.

Snake Envenoming: A Disease of Poverty

This study unequivocally demonstrates that snake envenoming is a disease of the poor, and the negative association between snakebite deaths and government expenditure on health confirms that the burden of mortality is highest in those countries least able to deal with the considerable financial cost of snakebite.

Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?

Recombinant antivenom based on oligoclonal mixtures of human IgG antibodies produced by CHO cell cultivation may be the key to obtaining better snakebite envenoming therapies and may in the future be a cost-competitive alternative to existing serum-based antivenoms.

Neurological complications of venomous snake bites: a review

Proper management of the envenomed patient, including prompt transport to the hospital, correction of the hemostatic disorder, ventilatory support, and administration of antivenom, significantly reduces the risk of neurological complications which, in turn, reduces the mortality and improve the functional outcome of survivors.

Bothrops lanceolatus Bites: Guidelines for Severity Assessment and Emergent Management

Despite an increasing incidence of bites, no deaths have been recently attributed to B. lanceolatus in Martinique, probably due to the currently recommended strategy of early antivenom administration when required, which is effective to prevent severe thrombosis and coagulopathy.

Effects of Bothrops asper Snake Venom on Lymphatic Vessels: Insights into a Hidden Aspect of Envenomation

Observations indicate that B. asper venom affects collecting lymphatic vessels through the action of myotoxic PLA2s on the smooth muscle of these vessels, inducing cell contraction and irreversible cell damage.

Snake Bite in South Asia: A Review

The deficiency of snake bite management in South Asia is multi-causal and requires joint collaborative efforts from researchers, antivenom manufacturers, policy makers, public health authorities and international funders.

Epidemiological aspects of snake bites on a Liberian rubber plantation.

During a one-year period 95 patients with a history of snake bite were admitted to the hospital of a Liberian rubber plantation, and a definite maximum of snake bites was observed during October and November which corresponds to the transition from rainy to dry season.